Across TCGA pan-cancer cohorts, ZNF273 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated ZNF273 data layer compared with 27 for mass-spec protein.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher ZNF273 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated ZNF273 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.
UCEC are the cancer types where ZNF273 Mutation most reproducibly stratifies survival.